MRES (Institute of Biomedical Research) Receivables Turnover: 0.00 (As of Dec. 2010)


What is Institute of Biomedical Research Receivables Turnover?

Institute of Biomedical Research MRES Receivables Turnover is 0.00 as of Dec. 2010.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Institute of Biomedical Research's Revenue for the three months ended in Dec. 2010 was $0.00 Mil. Institute of Biomedical Research's average Accounts Receivable for the three months ended in Dec. 2010 was $0.00 Mil.

Institute of Biomedical Research  (OTCPK:MRES) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Institute of Biomedical Research Receivables Turnover Related Terms

Institute of Biomedical Research Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research Receivables Turnover Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
Receivables Turnover
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MRES vs HSTC, NTRR, VITIF: Receivables Turnover Comparison

For the Biotechnology subindustry, Institute of Biomedical Research's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Institute of Biomedical Research Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Institute of Biomedical Research's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Institute of Biomedical Research's Receivables Turnover falls into.


Institute of Biomedical Research Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Institute of Biomedical Research's Receivables Turnover for the fiscal year that ended in Mar. 2010 is calculated as

Receivables Turnover (A: Mar. 2010 )
=Revenue / Average Accounts Receivable
=Revenue (A: Mar. 2010 ) / ((Accounts Receivable (A: Mar. 2009 ) + Accounts Receivable (A: Mar. 2010 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

Institute of Biomedical Research's Receivables Turnover for the quarter that ended in Dec. 2010 is calculated as

Receivables Turnover (Q: Dec. 2010 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2010 ) / ((Accounts Receivable (Q: Sep. 2010 ) + Accounts Receivable (Q: Dec. 2010 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
Institute of Biomedical Research (MRES) has a Receivables Turnover of 0.00 as of Dec. 2010. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's Receivables Turnover too high?
Institute of Biomedical Research's current Receivables Turnover is 0.00.
How does Institute of Biomedical Research's Receivables Turnover compare to HSTC and NTRR?
Institute of Biomedical Research's Receivables Turnover of 0.00 can be compared against companies in the Biotechnology industry. The industry median Receivables Turnover is 5.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.30, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Institute of Biomedical Research and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Institute of Biomedical Research's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current Receivables Turnover is 0.00 as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.